Rationale, Opportunities, and Reality of Biosimilar Medications
John R Zalcberg
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2018
Dr. Zalcberg reports receiving lecture fees and travel support from Pfizer and fees for serving on advisory boards from Pfizer and Amgen. No other potential conflict of interest relevant to this letter was reported.